GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...

Findings from a new study indicate a potential association between respiratory syncytial virus (RSV) infection and the later development of type 2 diabetes mellitus (T2DM). However, ...

Health officials are urging residents to take preventive steps such as vaccination, handwashing and staying home when sick.

Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER visits for RSV are “high” or “very high” in more than half of New Jersey ...

TidalHealth is lifting most masking requirements as flu, RSV and COVID cases decline, with some clinical settings still requiring masks.

The American Medical Association and a leading public health research group focused on vaccines are teaming up to create a ...

Despite a much milder winter so far this year, flu and other respiratory illness cases continue to rise and have ...

The AMA's evaluation will be done in collaboration with the Vaccine Integrity Project at the Center for Infectious Disease ...

The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine ...

(Alliance News) - GSK PLC on Tuesday said its respiratory syncytial virus vaccine Arexvy has been accepted for review by China's Center for Drug Evaluation for adults aged 60 and over. The ...

Norway, Denmark, and other countries with fewer childhood vaccines have another thing in common: paid parental leave.

Colorado is in the midst of a record-breaking flu season. In the week ending Dec. 27, 2025, 831 people were hospitalized with ...